Nanobac Pharmaceuticals, Incorporated (NNBP)

USD 0.0

(0.0%)

Revenue Summary of Nanobac Pharmaceuticals, Incorporated

  • Nanobac Pharmaceuticals, Incorporated's latest annual revenue in 2007 was 17.62 Thousand USD , down -92.17% from previous year.
  • Nanobac Pharmaceuticals, Incorporated's latest quarterly revenue in 2007 FY was 17.62 Thousand USD , down -92.17% from previous quarter.
  • Nanobac Pharmaceuticals, Incorporated reported a annual revenue of 225.08 Thousand USD in annual revenue 2006, down -65.73% from previous year.
  • Nanobac Pharmaceuticals, Incorporated reported a annual revenue of 656.8 Thousand USD in annual revenue 2005, up 83.28% from previous year.
  • Nanobac Pharmaceuticals, Incorporated reported a quarterly revenue of 17.62 Thousand USD for 2007 FY, down -92.17% from previous quarter.
  • Nanobac Pharmaceuticals, Incorporated reported a quarterly revenue of 4368.00 USD for 2007 Q4, down -24.81% from previous quarter.

Annual Revenue Chart of Nanobac Pharmaceuticals, Incorporated (2007 - 1994)

Historical Annual Revenue of Nanobac Pharmaceuticals, Incorporated (2007 - 1994)

Year Revenue Revenue Growth
2007 17.62 Thousand USD -92.17%
2006 225.08 Thousand USD -65.73%
2005 656.8 Thousand USD 83.28%
2004 358.36 Thousand USD -25.78%
2003 482.81 Thousand USD 4078.41%
2002 11.55 Thousand USD 0.0%
1999 6.84 Million USD -22.0%
1998 8.77 Million USD -11.74%
1997 9.94 Million USD 12.0%
1996 8.87 Million USD 43.17%
1995 6.2 Million USD 67.57%
1994 3.7 Million USD 0.0%

Peer Revenue Comparison of Nanobac Pharmaceuticals, Incorporated

Name Revenue Revenue Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD 76.73%
Evofem Biosciences, Inc. 18.21 Million USD 99.903%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.986%
Qrons Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 99.088%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 99.888%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 99.918%
Intellipharmaceutics International Inc. 65.72 Thousand USD 73.191%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 99.701%
Marizyme, Inc. 645.81 Thousand USD 97.271%
Genus plc 668.8 Million USD 99.997%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.993%
Therapeutic Solutions International, Inc. 98.99 Thousand USD 82.2%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 95.704%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD 77.044%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD 55.41%
MultiCell Technologies, Inc. 49.32 USD -35627.899%
ONE Bio Corp. 52.29 Million USD 99.966%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 99.965%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD 63.965%
Q BioMed Inc. 284.35 Thousand USD 93.803%
Emmaus Life Sciences, Inc. 29.59 Million USD 99.94%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.988%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 96.84%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 70 Thousand USD 74.827%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 97.324%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 100.0%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -1663.864%
Enzolytics Inc. 52.79 Thousand USD 66.624%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 97.104%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.999%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD 87.435%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 97.146%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.998%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 98.234%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 99.964%
BioStem Technologies, Inc. 16.68 Million USD 99.894%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD 92.551%
Regen BioPharma, Inc. 236.56 Thousand USD 92.551%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 98.713%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 96.28%
SYBLEU INC 11.69 Thousand USD -50.658%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 99.774%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -35.546%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD 55.428%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 99.471%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 99.736%
IntelGenx Technologies Corp. 1.03 Million USD 98.304%
Gelesis Holdings, Inc. 25.76 Million USD 99.932%
CSL Limited 14.8 Billion USD 100.0%
Cellectis S.A. 755 Thousand USD 97.666%